1 100 (300 ) ~9
16 Potential benefits for women in menopause Semaglutide could help postmenopausal women lose weight, restore insulin sensitivity, and achieve blood sugar control
Patients may be able to restart Wegovy after surgery once digestion hydration and normal eating patterns have recovered safely
While the average semaglutide patient can lose over 10% of their body weight (200 pounds = over 20 pounds) in the first 6 months of treatment, every person is unique and will experience weight loss at their own rate
In a recent study published in The Lancet, researchers performed a phase III randomized clinical trial (RCT) in nine countries across North America, Asia, and Europe to assess the effectiveness of semaglutide as the oral treatment of obesity in adults without type 2 diabetes (T2D)
, 204 , 403-416, Grillo, M